Holtermann, N <br/><br/>
The tyrosine kinase inhibitor toceranib in feline injection site sarcoma: efficacy and side effects.  [electronic resource] 

 -  Veterinary and comparative oncology  Jun 2017 
 - 632-640 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1476-5829 
<br/><br/><label>Standard No.: </label>10.1111/vco.12207  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--adverse effects<br/>Cat Diseases--drug therapy<br/>Cats<br/>Female<br/>Indoles--adverse effects<br/>Injections--adverse effects<br/>Male<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrroles--adverse effects<br/>Sarcoma--drug therapy<br/>Soft Tissue Neoplasms--drug therapy